best crypto to buy for long term 2021, Related searches

President of the Swiss National Bank: We will continue to monitor inflationary pressure and adjust monetary policy to maintain price stability if necessary. The president of the Swiss National Bank said that we will continue to monitor inflationary pressure and adjust monetary policy to maintain price stability if necessary. If there is no interest rate cut today, inflation expectations will be lower; The uncertainty of the future inflation path is still high.Zelensky's office stated that it was ready to negotiate with Russia. Mikhail Podolyak, adviser to the director of Ukrainian President Zelensky's office, said in an interview with Channel 24 that Kiev was ready to negotiate with Russia. He pointed out that simple solutions should not be expected, and Ukraine needs just peace conditions. Earlier, Kremlin spokesman dmitry Peskov said that Russia was willing to negotiate with Ukraine provided that the conditions proposed by Russian President Vladimir Putin were met. The conditions mentioned include the complete withdrawal of Ukrainian troops from new Russian regions and Ukraine's neutrality.IEA Monthly Report: The daily output of the refinery will reach the annual peak of 84.3 million barrels in December. It is estimated that in 2024, the daily output of the refinery will increase by 520,000 barrels to an average of 82.7 million barrels per day. It is estimated that in 2025, the daily output of refineries will increase by 620,000 barrels to an average of 83.3 million barrels per day.

The 2.53 billion shares held by Greenland Group have been frozen. According to the legal litigation information of Tianyancha, recently, Guangxi Construction Engineering Group Co., Ltd. added a piece of information on the freezing of shares. The executor is Greenland Holding Group Co., Ltd., and the amount of frozen shares is about 2.53 billion RMB. The freezing period is from December 9, 2024 to December 8, 2027. The enforcement court is Wanzhou District People's Court in Chongqing.The monkeypox vaccine with independent intellectual property rights in China was approved for clinical use. On December 10th, the monkeypox vaccine jointly developed by China Bio-Beijing Institute of Biological Products and China Center for Disease Control and Prevention received the approval notice of drug clinical trial issued by National Medical Products Administration, and it was registered and classified as Class 1.2 innovative vaccine. The vaccine is an innovative vaccine independently developed by scientists in China with completely independent intellectual property rights, which is expected to play an important role in the prevention and control of diseases caused by monkeypox virus in China. (China Biology)On the 12th, the South Korean National Assembly voted to impeach the Minister of Justice Park Hyung-jae and the Director of the Police Department Zhao Zhihao.

Ai Kelan: The actual controller intends to transfer 5% shares of the company by agreement. Ai Kelan announced that Liu Yi, the controlling shareholder and actual controller of the company, intends to transfer 4 million unrestricted shares of the company to Guangdong Nanchuan Private Equity Fund Management Co., Ltd. by agreement transfer, accounting for 5.00% of the company's total share capital. If the transaction is finally completed, Liu Yi holds 33.89% of the company's shares, and Nanchuan Private Equity holds 5.00% of the company's shares. This change in equity will not lead to changes in the controlling shareholder and actual controller of the company. The transfer of shares in this agreement can only be handled in Shenzhen Branch of China Securities Depository and Clearing Co., Ltd. after the compliance confirmation of Shenzhen Stock Exchange. The share transfer price of this transaction is 20.61 yuan/share.In the latest centralized purchase of sitagliptin tablets, the price dropped to less than 20 cents per tablet, with a drop of over 90%. The reporter learned at the scene of the tenth batch of drug centralized purchase that more than 30 companies bid for sitagliptin, which is known as the largest variety in this centralized purchase, including Huahai Pharmaceutical, Kelun Pharmaceutical, Zhengda Tianqing, tonghua dongbao, Zhejiang Pharmaceutical, Jiudian Pharmaceutical, Shiyao Ouyi, Chenxin Pharmaceutical and many other companies. Judging from the bidding results, the lowest bid price among enterprises has dropped below 0.2 yuan per piece, which is more than 90% lower than the limit price. Statistics show that in 2023, the sales of this product in the terminals of public medical institutions in China exceeded 2 billion yuan, and the sales of Merck, the original research manufacturer, accounted for more than 90%, so there is a large room for generic drug substitution. The quotation of Meradong in this collection is about 7.37 yuan per piece. (science and technology innovation board Daily)The Polish minister said that Poland hopes that more countries will participate in Baltic policing, the EU must spend at least 100 billion euros on national defense, and the conditions for sending Polish MIG -29 fighters to Ukraine have not been met.